Skip to main content
Clinical Trials/NCT02535377
NCT02535377
Completed
Not Applicable

Molecular Diagnostic of Sperm Cryoresistance of Semen Donors and Clinical Outcomes After Artificial Insemination. Optimization of Sperm Bank

Instituto Valenciano de Infertilidad, IVI Alicante1 site in 1 country40 target enrollmentStarted: February 12, 2015Last updated:
ConditionsFertility

Overview

Phase
Not Applicable
Status
Completed
Sponsor
Instituto Valenciano de Infertilidad, IVI Alicante
Enrollment
40
Locations
1
Primary Endpoint
Genomic profile of sperm samples depending on their survival resistance to cryopreservation

Overview

Brief Summary

Sperm freezing has been employed for decades for male fertility preservation in cases of foreseeable or unexpected loss of fertility to guarantee future paternity, and also as a complement of assisted reproduction techniques.

Sperm quality after thawing is highly variable, even among consecutive samples from the same individual, with mean survival rates around 40%. To date, the molecular basis of the adequate resistance or intolerance to freezing/thawing protocols is unknown, and its knowledge can lead to improvement in the selection of the samples to be frozen and also in the adequate supplement of cryopreservation media. Microarray analysis provides a powerful tool to address the molecular explanation beyond this behaviour, yielding results about comparative messenger ribonucleic acid (mRNA)expression under the two different biological conditions: optimal and suboptimal survival.

Then, the aim of the investigators' study is to determine the genomic profile of sperm samples depending on their survival resistance to cryopreservation, to determine genes involved in cryodamage sensitivity.

Detailed Description

Nested cases and controls design, with donor sperm samples frozen under conventional protocols, categorized depending on their good (GSR, n=20) (less than 20% motility decrease) or bad (BSR, n=20) (more than 20% motility decrease) survival rates. Sperm mRNA was extracted using Trizol protocol, suspended in diethylpyrocarbonate (DEPC)-treated water and frozen at -80 degrees until the microarray experiments were performed. RNAs were analyzed on Agilent Bioanalyzer 2100. Samples were pooled in 4 (5 samples/pool and 4 pools/group). Finally, 8 Agilent One colour Whole genome microarray (44K) were performed with pooled samples, 4 microarrays per group.

The results will be evaluate to detect those genes differentially expressed.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Eligibility Criteria

Ages
18 Years to 35 Years (Adult)
Sex
Male
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • The criteria used for the inclusion of donors in the sperm bank will be considered:
  • males from 18 to 35 years.
  • good physical and psychological conditions and no hereditary diseases
  • seminal parameters: concentration \> 40 million sperm / ml; percentage of progressive motility\> 50% percentage of normal forms\> 4%.
  • For pregnancy rates after artificial insemination, only women\< 40 years without tubal pathologies and artificial insemination indications will be included.

Exclusion Criteria

  • All the population not included in the list of inclusion will be excluded.

Outcomes

Primary Outcomes

Genomic profile of sperm samples depending on their survival resistance to cryopreservation

Time Frame: A year and a half

The genomic profile of sperm samples depending on their survival resistance to cryopreservation will be analysed and expressed as: * Common or differentially expressed genes: in case of genes expressed in both groups * Exclusive Genes, in case of genes expressed just in one group

Secondary Outcomes

  • Pregnancy rates after artificial insemination with donor semen in the different groups.(two years)

Investigators

Sponsor
Instituto Valenciano de Infertilidad, IVI Alicante
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Elena Sellés Soriano

Molecular diagnostic of sperm cryoresistance of semen donors and clinical outcomes after artificial insemination. Optimization of sperm bank

Instituto Valenciano de Infertilidad, IVI Alicante

Study Sites (1)

Loading locations...

Similar Trials